This inventor holds 3 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Merck Sharp & Dohme LLC, Merck Sharp + Dohme Corp.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations by Rebecca Elizabeth Johnson
Introduction
Rebecca Elizabeth Johnson is a notable inventor based in Oakland, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target LRRK2 kinase, which is associated with various diseases, including Parkinson's Disease.
Latest Patents
Rebecca holds a patent for her invention titled "1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof." This invention focuses on certain substituted 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives that are potent inhibitors of LRRK2 kinase. These compounds may be useful in the treatment or prevention of diseases where LRRK2 kinase is involved, such as Parkinson's Disease.
Career Highlights
Rebecca is currently associated with Merck Sharp & Dohme Corporation, where she continues to innovate and contribute to pharmaceutical research. Her work has the potential to impact the treatment of serious neurological conditions.
Collaborations
Throughout her career, Rebecca has collaborated with esteemed colleagues, including Hua Zhou and John J Acton, III. These collaborations have likely enhanced her research and development efforts in the pharmaceutical field.
Conclusion
Rebecca Elizabeth Johnson exemplifies the spirit of innovation in the pharmaceutical industry. Her work on LRRK2 inhibitors
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile